TMEM30CP

Across TCGA pan-cancer cohorts, TMEM30CP RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated TMEM30CP data layer.

The strongest signal is observed in kidney chromophobe (KICH), where higher TMEM30CP RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated TMEM30CP expression acts as an unfavorable survival marker, although some lineages such as BLCA and HNSC show a favorable association.

KICH, ACC, and DLBC are the cancer types where TMEM30CP RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KICH	DFS	Tertile	All	0.565	0.938	.004	96	view →
ACC	OS	Tertile	All	0.577	0.912	.002	54	view →
DLBC	OS	Tertile	All	0.716	1.000	.003	53	view →
MESO	OS	Quartile	All	0.388	0.599	.007	52	view →
KIRC	OS	Quartile	II,III,IV	0.407	0.579	.009	46	view →
BLCA	DFS	Tertile	III,IV	0.578	0.282	.006	41	view →
LIHC	OS	Tertile	All	0.584	0.806	.001	39	view →
COAD	OS	Tertile	IV	0.166	0.708	<.001	33	view →
THYM	OS	Tertile	All	0.887	0.974	.014	27	view →
PCPG	OS	Tertile	All	0.851	0.986	.001	24	view →
LUAD	OS	Tertile	IV	0.403	0.754	.022	18	view →
READ	OS	Tertile	IV	0.077	1.000	.014	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

TMEM30CP–KICH (DFS)

Open the KICH breakdown →